October 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Axogen, Inc. (“Axogen” or “the Company”) (NASDAQ: AXGN). Investors who purchased Axogen securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Axogen has violated federal… read more
September 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rezolve AI plc (“Rezolve” or “the Company”) (NASDAQ: RZLV). Investors who purchased Rezolve securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Rezolve has violated… read more
September 30, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Brunello Cucinelli S.p.A. (“Brunello Cucinelli” or “the Company”) (OTCMKTS: BCUCY). Investors who purchased Brunello Cucinelli securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Brunello… read more
September 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sable Offshore Corp. (“Sable” or “the Company”) (NYSE: SOC). Investors who purchased Sable securities prior to May 21, 2025, and continue to hold to the present, are encouraged to obtain additional… read more
September 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of SSR Mining Inc. (“SSR Mining” or “the Company”) (TSX: SRRM). Investors who purchased SSR Mining securities prior to February 23, 2022, and continue to hold to the present, are encouraged to… read more
September 17, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Capricor Therapeutics, Inc. (“Capricor” or “the Company”) (NASDAQ: CAPR). Investors who purchased Capricor securities prior to October 9, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MediaAlpha, Inc. (“MediaAlpha” or “the Company”) (NYSE: MAX). Investors who purchased MediaAlpha securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MediaAlpha has violated federal… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Celanese Corporation (“Celanese” or “the Company”) (NYSE: CE). Investors who purchased Celanese securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Celanese has violated federal… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Galiano Gold Inc. (“Galiano” or “the Company”) (NYSE: GAU). Investors who purchased Galiano securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Galiano has violated… read more
September 16, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating the MeridianLink, Inc. (“MeridianLink”) (NYSE: MLNK) acquisition by funds advised by affiliates of Centerbridge Partners, L.P. (“Centerbridge”), a global investment firm. Investors who purchased MeridianLink and continue to hold to the present are encouraged to obtain additional information… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of America’s Car-Mart, Inc. (“Car-Mart” or “the Company”) (NASDAQ: CRMT). Investors who purchased Car-Mart securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Car-Mart has violated… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Lesaka Technologies, Inc. (“Lesaka” or “the Company”) (NASDAQ: LSAK). Investors who purchased Lesaka securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Lesaka has violated… read more
September 15, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Skillz Inc. (“Skillz” or “the Company”) (NYSE: SKLZ). Investors who purchased Skillz securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Skillz has violated federal… read more
September 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Generac Holdings Inc. (“Generac” or “the Company”) (NYSE: GNRC). Investors who purchased Generac securities prior to May 3, 2023, and continue to hold to the present, are encouraged to obtain additional… read more
September 12, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Cybin Inc. (“Cybin” or “the Company”) (NYSE: CYBN). Investors who purchased Cybin securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Cybin has violated federal… read more
September 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Matrix Service Company (“Matrix” or “the Company”) (NASDAQ: MTRX). Investors who purchased Matrix securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Matrix has violated… read more
September 11, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Coherent Corp. (“Coherent” or “the Company”) (NYSE: COHR). Investors who purchased Coherent securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Coherent has violated federal… read more
September 10, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Summit Therapeutics Inc. (“Summit” or “the Company”) (NASDAQ: SMMT). Investors who purchased Summit securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Summit has violated… read more
September 8, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Applied Therapeutics, Inc. (“Applied Therapeutics” or “the Company”) (NASDAQ: APLT). Investors who purchased Applied Therapeutics securities prior to January 3, 2024, and continue to hold to the present, are encouraged to… read more
September 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Agios Pharmaceuticals, Inc. (“Agios” or “the Company”) (NASDAQ: AGIO). Investors who purchased Agios securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Agios has violated… read more
September 5, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Barnes & Noble Education, Inc. (“Barnes & Noble” or “the Company”) (NYSE: BNED). Investors who purchased Barnes & Noble securities are encouraged to obtain additional information and assist the investigation. The… read more
September 3, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of MarineMax, Inc. (“MarineMax” or “the Company”) (NYSE: HZO). Investors who purchased MarineMax securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether MarineMax has violated federal… read more
September 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of EHang Holdings Limited (“EHang” or “the Company”) (NASDAQ: EH). Investors who purchased EHang securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether EHang has violated… read more
September 2, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Valneva SE (“Valneva” or “the Company”) (NASDAQ: VALN). Investors who purchased Valneva securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Valneva has violated federal… read more
August 29, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Insperity, Inc. (“Insperity” or “the Company”) (NYSE: NSP). Investors who purchased Insperity securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Insperity has violated federal… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of 3D Systems Corporation (“3D Systems” or “the Company”) (NYSE: DDD). Investors who purchased 3D Systems securities prior to August 13, 2024, and continue to hold to the present, are encouraged to… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Rocket Pharmaceuticals, Inc. (“Rocket” or “the Company”) (NASDAQ: RCKT). Investors who purchased Rocket securities prior to September 17, 2024, and continue to hold to the present, are encouraged to obtain additional… read more
August 26, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of PepGen Inc. (“PepGen” or “the Company”) (NASDAQ: PEPG). Investors who purchased PepGen securities prior to March 7, 2024, and continue to hold to the present, are encouraged to obtain additional information… read more
August 25, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Sensus Healthcare, Inc. (“Sensus” or “the Company”) (NASDAQ: SRTS). Investors who purchased Sensus securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether Sensus has violated… read more
August 22, 2025 |
Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Innovative Solutions and Support, Inc. (“IS&S” or “the Company”) (NASDAQ: ISSC). Investors who purchased IS&S securities are encouraged to obtain additional information and assist the investigation. The investigation concerns whether IS&S… read more